Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
Saif Al-Shamsi, Dybesh Regmi, Romona D Govender
https://pubmed.ncbi.nlm.nih.gov/31208354Actively Recruiting
Age: 18Years +
All Genders
ID06535503
Clinical Characteristics and Outcomes Among ST-elevation Myocardial Infarction Patients With Cardiogenic Shock in Abu Dhabi
Led by Abu Dhabi Health Services Company · Updated on 2025-02-17
400
Participants Needed
2
Research Sites
21 weeks
Total Duration
On this page
Sponsors
A
Abu Dhabi Health Services Company
Lead Sponsor
S
Sheikh Shakhbout Medical City
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are conducting a retrospective observational study to examine patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated by cardiogenic shock (CS), either at admission or developed during hospital stay. The study focuses on two tertiary hospitals in Abu Dhabi, UAE, covering patient data from 2020 to 2024. The goal is to understand patient characteristics, treatment trends, hospitalization events, and outcomes for this serious cardiovascular condition in the region. The study collects data from electronic medical records of eligible patients treated at Sheikh Khalifa Medical City (SKMC) and Sheikh Shakhbout Medical City (SSMC). It includes patients admitted with STEMI complicated by CS, looking at treatments provided and how patients responded during their hospital stay. This analysis spans a five-year period from January 2019 to March 2024. Participants' involvement includes reviewing their medical records to analyze disease profiles and treatment outcomes over five years. Researchers will assess the incidence of cardiogenic shock complicated acute myocardial infarction events and evaluate recovery or mortality factors. The study does not involve direct treatment or interventions but uses historical data to measure outcomes and trends related to STEMI and cardiogenic shock.
CONDITIONS
Brief Title
Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Age more than 18.
- STEMI complicated by cardiogenic shock.
- Hospitalized or treated at Sheikh Khalifa Medical City or Sheikh Shakhbout Medical City for STEMI complicated by cardiogenic shock.
- Admitted between January 2019 to March 2024.
You will not qualify if you...
- Age less than 18.
- Cardiogenic shock not related to myocardial infarction.
- Cardiogenic shock related to NSTEMI.
- Not treated at Sheikh Khalifa Medical City or Sheikh Shakhbout Medical City for STEMI complicated by cardiogenic shock.
- Not admitted between January 2019 to March 2024.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Monitoring
Duration - Up to 5 years
Participants who were admitted with STEMI complicated by cardiogenic shock are observed through collection of data from their electronic medical records to study treatment modalities, hospitalization events, and outcomes.
No visits required; data collected retrospectively from medical records
Trial Site Locations
Total: 2 locations
1
Sheikh Khalifa Medical City (SKMC)
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 11001
Actively Recruiting
2
Sheikh Shakhbout Medical City (SKMC)
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 11001
Actively Recruiting
Loading map...
Research Team
A
Alina Naeem, MBBS
B
Babiker Babiker Mohamed Babiker Elsiraj MB Elsiraj, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes.
Leonardo De Luca, Zoran Olivari, Andrea Farina...
https://pubmed.ncbi.nlm.nih.gov/26339723Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
D R Holmes, E R Bates, N S Kleiman...
https://pubmed.ncbi.nlm.nih.gov/7642857Cardiogenic Shock Among Patients with Acute ST-Segment Elevation Myocardial Infarction in a Middle Eastern Country: A Single-Center Experience.
Ghada Shalaby, Azmat K Niazi, Sheeren Khaled
https://pubmed.ncbi.nlm.nih.gov/36816794Opportunistic Screening for CVD Risk Factors: The Dubai Shopping for Cardiovascular Risk Study (DISCOVERY).
Afzalhussein Yusufali, Nooshin Bazargani, Khalifa Muhammed...
https://pubmed.ncbi.nlm.nih.gov/26271552